Encompass Health Corporation (EHC) Cash Flow Statement

The persistent gap between net income and operating cash flow indicates that the company's accounting earnings are heavily influenced by the depreciation of its extensive facility footprint. Investors should monitor whether this cash conversion remains stable as the company continues its aggressive de novo expansion strategy, which will likely keep depreciation levels elevated.

The negative free cash flow observed in recent periods highlights the capital-intensive nature of the inpatient rehabilitation business model. This volatility suggests that the company's ability to self-fund growth is constrained by its commitment to expanding its physical footprint, necessitating careful scrutiny of future capital allocation priorities.

The high capital intensity suggests that Encompass Health is prioritizing long-term capacity growth over immediate cash return to shareholders. While these investments are intended to build a competitive moat, the reliance on heavy reinvestment implies that the company's cash flow profile will remain sensitive to the timing and success of these de novo projects.

The simultaneous pursuit of aggressive expansion and shareholder distributions warrants further investigation into the sustainability of this dual-track strategy. If reimbursement rates face downward pressure, the company may be forced to choose between maintaining its dividend and continuing its current pace of facility development.